TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 303 filers reported holding TANDEM DIABETES CARE INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $330,529 | -39.5% | 13,469 | +0.0% | 0.16% | -43.1% |
Q1 2023 | $546,773 | +89977.9% | 13,464 | -0.4% | 0.27% | -11.9% |
Q4 2022 | $607 | -99.9% | 13,512 | -0.7% | 0.31% | -12.9% |
Q3 2022 | $651,000 | -16.3% | 13,608 | +3.5% | 0.36% | -13.3% |
Q2 2022 | $778,000 | -49.2% | 13,148 | -0.2% | 0.41% | -42.5% |
Q1 2022 | $1,532,000 | -23.1% | 13,171 | -0.5% | 0.72% | -12.8% |
Q4 2021 | $1,992,000 | -13.7% | 13,235 | -31.6% | 0.82% | -21.6% |
Q3 2021 | $2,308,000 | -3.2% | 19,336 | -21.0% | 1.05% | +28.8% |
Q2 2021 | $2,385,000 | +6.9% | 24,484 | -3.2% | 0.81% | +9.9% |
Q1 2021 | $2,232,000 | -8.7% | 25,294 | -1.0% | 0.74% | -20.3% |
Q4 2020 | $2,445,000 | -16.6% | 25,555 | -1.0% | 0.93% | -33.7% |
Q3 2020 | $2,931,000 | +4.6% | 25,821 | -8.8% | 1.40% | +8.9% |
Q2 2020 | $2,802,000 | +33.4% | 28,324 | -13.2% | 1.28% | +26.4% |
Q1 2020 | $2,101,000 | +23.8% | 32,647 | +14.7% | 1.02% | +45.7% |
Q4 2019 | $1,697,000 | – | 28,469 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |